Future Market Insights10h
In Vitro Diagnostics Market to Reach USD 129.9 Billion by 2033 at a 4.8% of CAGR, Driven by Technological Advancements and Rising Health Awareness
The global in vitro diagnostics (IVD) market is projected to grow steadily at a CAGR of 4.8%, increasing from USD 81.3 ...
IVD in Cardiology and Neurology Market to Surge to USD 48.36 Billion by 2034, Propelled by Technological Advancements and Increasing Disease Burden
The "IVD In Cardiology and Neurology Market by Product Type, by Technology, by End-User, and By Region" report has been added ...
FierceBiotech2d
FDA's diagnostics CMO named interim agency commissioner
The FDA has tapped Sara Brenner to serve as acting commissioner as it awaits new leadership from the Trump administration to ...
FierceBiotech8d
Inflammatix collects FDA clearance for ER sepsis diagnostic test
Inflammatix has secured the FDA’s blessing for its in vitro diagnostic system, aimed at rapidly profiling the body’s response ...
Accelerate Diagnostics (NASDAQ:AXDX) Stock Price Passes Below Two Hundred Day Moving Average – What’s Next?
Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Get Free Report) shares passed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $1.54 ...
BioPorto announces the publication of urinary NGAL reference ranges in healthy adult and pediatric individuals
The publication can be found here: Determination of Urinary Neutrophil Gelatinase-Associated Lipocalin (uNGAL) Reference Intervals in Healthy Adult and Pediatric Individuals Using a Particle-Enhanced ...
Erba Transasia group introduces advanced haematology analyzer in Telangana and Andhra Pradesh
Erba Transasia Group, India’s No. 1 In-vitro Diagnostic (IVD) Company and among the leading global IVD players focused on ...
Anbio Biotechnology to Showcase Cutting-Edge Diagnostic Solutions at 2025 Medlab Middle East
Anbio Biotechnology ("Anbio"), a global leader in in-vitro diagnostic technologies, is excited to announce its participation ...
Erba Transasia Group introduces advanced haematology analyzer in Karnataka
Erba Transasia Group, India’s No. 1 In-vitro Diagnostic (IVD) Company and among the leading global IVD players focused on emerging markets, today introduced Erba H7100 – its advanced Haematology ...
Erba Transasia group introduces its’ advanced haematology analyzer in Tamil Nadu
Erba Transasia Group, India’s No. 1 In-vitro Diagnostic (IVD) Company and among the leading global IVD players focused on ...